Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Oct 13, 2020 11:54am
129 Views
Post# 31707216

RE:Who sells at this price????

RE:Who sells at this price????It never makes sense with this stock. Why did stock scream up to $31USD with high volume
at those prices. I have to think it was one house  selling to itself manipulating or else someone lost 50% in a day! Never has made sense but pre-revenue companies can't be validated well. 

PSB wrote:
I realize the stock float is very low and there can be quite a difference between the bid and ask at times, but who is selling at this price? We have a new PDUFA date of March 5/21 with a possible PRV voucher along with an approval. This approval could happen well before the PDUFA date of March 5/21 especially when this is the second go around for this company regarding filing a BLA for Ryplazim. I can understand the share price sitting close to the rights offering price, but this price is ridiclous and doesn't make sense to me.


<< Previous
Bullboard Posts
Next >>